|Basic InformationLookupsLatest News|EHR-Based Prompt Ups Hepatitis C Screening for Baby BoomersTravelers to Europe Need Measles Protection: CDCLaser Therapy Shows Promise Against Eye 'Floaters'Health Tip: Ease the Pain of a BlisterChronic Disease Risk Rises With Even Slow, Steady Weight GainAs Your Weight Creeps Up, So Does Your Risk of Heart FailureResearchers Grow Functioning Liver Tissue in MiceMore Than 100 Million Americans Have Diabetes or Prediabetes: CDCMeasles Outbreak Identified in Minnesota Is OngoingMore Evidence That Midlife Weight Gain Harms Your HealthReducing Repeat Hospitalizations Doesn't Harm Patients: StudyImpaired Eyesight May Be First Sign of Zika Damage in BabiesSome Medicines Boost Sensitivity to Sun9/11 Survivors More Likely to Have Heart, Lung DiseasesCould Artificial Sweeteners Raise Your Odds for Obesity?Many Americans Unaware of This Year's Heavy Tick Season: PollAfter Sunburn, High-Dose Vitamin D Cuts Inflammatory MediatorsHealth Tip: At Risk of Heat Illness?Working Too Much Might Tip Heart Into Irregular RhythmQuitting Smoking Can Bring Healthier Sinuses Years Later: StudyThyroid Problems May Make Things Worse for Dialysis PatientsWhite Collar Workers at Higher Odds of Death From ALS, Parkinson'sExperimental Vaccines Might Shield Fetus From ZikaStudy Spots Cause of Global Outbreak of Infections Tied to Heart SurgeriesEducation Can Boost Knowledge, Cut Anxiety in GlaucomaReview: Little Evidence on Vitamin D-Allergy AssociationClimate Change Delivers 'Double Whammy' to 4 in 10 AmericansHealth Tip: Battling Muscle Cramps?Too Few Children Get EpiPen When Needed: StudyCPAP Mask Not a Prescription for Heart TroublesNew Criteria Urged for Infection Diagnosis Among Seniors in EREarly Parkinson's May Prompt Vision ProblemsParkinson's Patients Deemed at Higher Risk of MelanomaViagra Might Make for a Safer, More Effective StentDaily Jolt of Java May Bring Longer LifeFDA Approves Endari for the Treatment of Sickle Cell DiseaseIncreasing BMI Causally Linked to Asthma, Not Hay FeverShield Yourself From 'Swimmer's Ear'Keep Legionnaire's Disease From Spoiling Your VacationNew Opioid Use in Older Adults With COPD May Up Cardiac EventsParkinson's Disease and Melanoma May Occur Together, Study FindsRecurring Intestinal Infections on the Rise in U.S.: StudyFDA Approves New Drug for Sickle Cell DiseaseHealth Tip: Do I Need a Zika Test?Shortage of Bee, Wasp Venom Stings Those With AllergiesAre Doctors Discarding Donor Kidneys That Could Save Lives?Herpes Zoster May Increase Risk of Myocardial Infarction, StrokeHyperbaric Oxygen Therapy Increasingly Being UsedOpioids a Threat to Seniors With COPDHealth Tip: Are You at Risk for a Herniated Disk?Questions and AnswersLinksBook Reviews
A 2nd Life for Risky Kidney Transplants?
by -- Mary Elizabeth Dallas
Updated: May 11th 2017
THURSDAY, May 11, 2017 (HealthDay News) -- Philadelphia doctors say they cleared hepatitis C infections in 10 patients who received kidneys from deceased donors who had the virus.
The findings suggest hundreds more of these transplants could take place each year, thus reducing wait time for a lifesaving kidney, the doctors said.
"Our pilot data demonstrate the ability to cure the contracted virus following transplantation in this patient population," said the study co-leader, Dr. David Goldberg.
"If future studies are successful, this may be a viable option for patients who may otherwise never see a transplant," added Goldberg, an assistant professor of medicine and epidemiology at the University of Pennsylvania School of Medicine.
In the United States, more than 97,000 people need a kidney transplant. Many must wait for five or more years, the researchers said in background notes.
Kidneys from donors with hepatitis C have been considered unsuitable. But, in 2016, researchers at Penn Medicine began investigating the effectiveness of transplants from donors with hepatitis C.
The kidneys were given to patients between 40 and 65 years old who had waited for at least a year and a half. Patients and their families underwent a thorough vetting process, to make sure they understood the risks involved.
"We started this trial in the hopes that, if successful, we could open up an entirely new pool of donor organs, and effectively transplant hundreds, if not thousands, more patients who are awaiting a lifesaving organ," said Goldberg. "Historically, hepatitis C-infected kidneys were often discarded, and were thought to be damaged or too 'high-risk.' "
After receiving the donor kidneys, all 10 patients tested positive for hepatitis C. All were treated with a 12-week antiviral therapy, known as elbasvir/grazoprevir, or Zepatier.
Early data from the study revealed this treatment effectively cleared hepatitis C from all of the patients.
"For so long, [hepatitis C] was a virus with a very negative stigma associated with it, especially among physicians. So it was interesting to see that patients were quick to jump at the chance to get this transplant, despite the possibility that they could get hepatitis C permanently," said the study's co-leader, Dr. Peter Reese.
Reese, an assistant professor of medicine and epidemiology, chairs the United Network of Organ Sharing's ethics committee.
"Going into the study, we knew it was a possibility that some or all of the patients would contract [hepatitis C], and that they could have the disease for the rest of their lives if we were unsuccessful. But for these patients, getting off of dialysis and getting back to their normal lives was very much worth the risk," Reese said.
The findings were presented at a recent meeting of the American Society of Transplant Surgeons and the American Society of Transplantation in Chicago. They were also published April 30 in the New England Journal of Medicine.
The U.S. Centers for Disease Control and Prevention provides more information on hepatitis C.
This article: Copyright © 2017 HealthDay. All rights reserved.